Improving stroke outcome: The benefits of increasing availability of technology

Bulletin of the World Health Organization

Volumn 78, Issue 11, 2000, Pages 1337-1343

  Heller, Richard F ^a,b   Langhorne, Peter ^c   James, Erica ^d  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

Aspirin, therapeutic use; Cerebrovascular accident, mortality; Cerebrovascular accident, therapy; Decision support techniques; Tomography scanners; Treatment outcome

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT;

ANTICOAGULATION; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FIBRINOLYTIC THERAPY; HEALTH CARE AVAILABILITY; HOSPITAL CARE; HUMAN; MEDICAL DECISION MAKING; MEDICAL TECHNOLOGY; MORTALITY; RISK BENEFIT ANALYSIS; STROKE; TREATMENT OUTCOME;

CEREBROVASCULAR ACCIDENT; DECISION SUPPORT TECHNIQUES; FIBRINOLYTIC AGENTS; GREAT BRITAIN; HUMANS; QUALITY ASSURANCE, HEALTH CARE; TECHNOLOGY ASSESSMENT, BIOMEDICAL; THROMBOLYTIC THERAPY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 0033739921     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Further evolution toward effective therapy for acute ischemic stroke
2. Guidelines for the management of patients with acute ischaernic stroke: A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association
3. Consensus in stroke management?
4. A prospective study of acute cerebrovascular disease in the community: The Oxfordshire Community Stroke Project 1981-86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage
5. Determining the incidence of different subtypes of stroke: Results from the Perth Community Stroke Study, 1989-1990
6. Non-rheumatic atrial fibrillation as a risk factor for stroke
7. Atrial fibrillation and stroke: Prevalence in different types of stroke and influence on early and long term prognosis (Oxfordshire Community Stroke Project)
8. Classification and natural history of clinically identifiable subtypes of cerebral infarction
9. Mortality in acute stroke with atrial fibrillation
10. The International Stroke Trial (IST): A randomised controlled trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke
11. Systematic review of evidence on thrombolytic therapy for acute stroke
12. CAST: Randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke
13. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke
14. How do stroke units improve patient outcomes? A collaborative systematic review of the randomised trials
15. Antithrombolitic therapy in acute ischaemic stroke: An overview of the completed randomised controlled trials
16. Variation in in-patient stroke management in ten centres in different countries. The INCLEN multicentre stroke collaboration
17. Collaborative overview of randomised trials of antiplatelet therapy-1: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
18. A randomised, blinded, trial of clopidrogel versus aspirin in patients at risk of ischaemic events (CAPRIE)
19. Poor accuracy of stroke scoring systems for differential diagnosis of intracranial haemorrhage and infarction
20. Why are patients with acute stroke admitted to hospital? The experience of the Oxfordshire Community Stroke Project
21. The stroke data bank: Design, methods and baseline characteristics
22. Cardiogenic stroke, early anticoagulation and brain haemorrhage
23. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke